Stanley C. Erck
2019
In 2019, Stanley C. Erck earned a total compensation of $2.4M as President and CEO at Novavax, a 41% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $366,351 |
|---|---|
| Option Awards | $986,660 |
| Salary | $642,720 |
| Stock Awards | $431,631 |
| Other | $11,200 |
| Total | $2,438,562 |
Erck received $986.7K in option awards, accounting for 40% of the total pay in 2019.
Erck also received $366.4K in non-equity incentive plan, $642.7K in salary, $431.6K in stock awards and $11.2K in other compensation.
Rankings
In 2019, Stanley C. Erck's compensation ranked 4,970th out of 13,971 executives tracked by ExecPay. In other words, Erck earned more than 64.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,970 out of 13,971 | 64th |
Division Manufacturing | 1,848 out of 5,698 | 68th |
Major group Chemicals And Allied Products | 652 out of 2,197 | 70th |
Industry group Drugs | 550 out of 1,883 | 71st |
Industry Biological Products, Except Diagnostic Substances | 123 out of 389 | 68th |
Pay ratio
| Stanley C. Erck's Pay | $2,438,562 |
|---|---|
| Median Employee's Pay | $98,413 |
| Pay Ratio | 25to 1 |
In 2019, the annual total compensation of Stanley C. Erck was $2,438,562.
The annual total compensation of the median employee at Novavax was $98,413.
The ratio of Stanley C. Erck's pay to the pay of median employee was therefore 25 to one.
Source: SEC filing on May 12, 2020.
Erck's colleagues
We found three more compensation records of executives who worked with Stanley C. Erck at Novavax in 2019.